Cargando…

Fibroblast Growth Factor 23 and Cardiovascular Risk in Diabetes Patients—Cardiologists Be Aware

Numerous clinical studies have indicated that elevated FGF23 (fibroblast growth factor 23) levels may be associated with cardiovascular (CV) mortality, especially in patients with chronic kidney disease. The purpose of this study was to examine the hypothesis that FGF23 may be a potent CV risk facto...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kurpas, Anna, Supel, Karolina, Wieczorkiewicz, Paulina, Bodalska Duleba, Joanna, Zielinska, Marzenna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9254740/ https://www.ncbi.nlm.nih.gov/pubmed/35736431 http://dx.doi.org/10.3390/metabo12060498

Ejemplares similares

Fibroblast Growth Factor 23: Potential Marker of Invisible Heart Damage in Diabetic Population
por: Kurpas, Anna, et al.
Publicado: (2023)

FGF23: A Review of Its Role in Mineral Metabolism and Renal and Cardiovascular Disease
por: Kurpas, Anna, et al.
Publicado: (2021)

2D Strain Analysis in Myocarditis—Can We Be Any Closer to Diagnose the Acute Phase of the Disease?
por: Supeł, Karolina, et al.
Publicado: (2023)

Symptomatic Young Adults with ST-Segment Elevation—Acute Coronary Syndrome or Myocarditis: The Three-Factor Diagnostic Model
por: Wieczorkiewicz, Paulina, et al.
Publicado: (2022)

Acute coronary syndrome versus acute myocarditis in young adults–value of speckle tracking echocardiography
por: Wieczorkiewicz, Paulina, et al.
Publicado: (2022)

Shock index and TIMI risk index as valuable prognostic tools in patients with acute coronary syndrome complicated by cardiogenic shock
por: Supeł, Karolina, et al.
Publicado: (2020)

Unexpected cause of syncope in a young woman
por: Supel, Karolina, et al.
Publicado: (2013)

Midregional pro-atrial natriuretic peptide, an important member of the natriuretic peptide family: potential role in diagnosis and prognosis of cardiovascular disease
por: Idzikowska, Karolina, et al.
Publicado: (2018)

Cardiologists and diabetes
por: Öngen, Zeki
Publicado: (2016)

Awareness of fitness to drive among cardiologists in Saudi Arabia
por: Abazid, Rami M., et al.
Publicado: (2019)

Is fibroblast growth factor 23 a new cardiovascular risk marker in gestational diabetes?
por: Kizilgul, Muhammed, et al.
Publicado: (2017)

Cardiac rehabilitation knowledge, awareness, and practice among cardiologists in India
por: Ghisi, Gabriela Lima de Melo, et al.
Publicado: (2018)

Current Challenges of Cardiac Amyloidosis Awareness among Romanian Cardiologists
por: Adam, Robert, et al.
Publicado: (2021)

Phosphate and fibroblast growth factor 23 in diabetes
por: van der Vaart, Amarens, et al.
Publicado: (2021)

Cardiovascular Interactions between Fibroblast Growth Factor-23 and Angiotensin II
por: Pi, Min, et al.
Publicado: (2018)

Implicit Gender Bias and the Use of Cardiovascular Tests Among Cardiologists
por: Daugherty, Stacie L., et al.
Publicado: (2017)

Is defining cardiologists important to curb cardiovascular disease epidemics?
por: Gupta, Vitull K., et al.
Publicado: (2016)

1,5-Anhydroglucitol as a Marker of Acute Hyperglycemia in Cardiovascular Events
por: Migała, Marta, et al.
Publicado: (2022)

Attitudes and Performance of Cardiologists Toward Sexual Issues in Cardiovascular Patients
por: Salehian, Razieh, et al.
Publicado: (2016)

Cardiologist perceptions of family-centred rounds in cardiovascular clinical care
por: Ludmir, Jonathan, et al.
Publicado: (2018)

A Practical Guide for Cardiologists to the Pharmacological Treatment of Patients with Type 2 Diabetes and Cardiovascular Disease
por: Ahmad, Tariq, et al.
Publicado: (2021)

Diagnosis of Amyloidosis: A Survey of Current Awareness and Clinical Challenges Among Cardiologists in Switzerland
por: Mircsof, Dennis
Publicado: (2020)

What do cardiologists know about the effects of cardiovascular agents on sexual function? A survey among Dutch cardiologists. Part I
por: Nicolai, M. P. J., et al.
Publicado: (2013)

Pathophysiological Implications of Imbalances in Fibroblast Growth Factor 23 in the Development of Diabetes
por: Donate-Correa, Javier, et al.
Publicado: (2021)

Fibroblast Growth Factor-23 and Risk of Cardiovascular Diseases: a Mendelian Randomization study
por: Donovan, Killian, et al.
Publicado: (2023)

Fibroblast Growth Factor 23 and Incident Cardiovascular Disease and Mortality in Middle‐Aged Adults
por: Paul, Shejuti, et al.
Publicado: (2021)

Remote Ischemic Preconditioning and Contrast-Induced Acute Kidney Injury in Patients Undergoing Elective Percutaneous Coronary Intervention: A Randomized Clinical Trial
por: Stokfisz, Karolina, et al.
Publicado: (2020)

Artificial intelligence in cardiovascular imaging: state of the art and implications for the imaging cardiologist
por: Siegersma, K. R., et al.
Publicado: (2019)

Pediatric Medical Devices　― Survey of Pediatric Cardiologists and Cardiovascular Surgeons in Japan ―
por: Miyoshi, Takekazu, et al.
Publicado: (2021)

Cardiovascular Critical Care Training: A Collaboration between Intensivists and Cardiologists
por: Yuriditsky, Eugene, et al.
Publicado: (2022)

A cardiologist’s guide to machine learning in cardiovascular disease prognosis prediction
por: Kresoja, Karl-Patrik, et al.
Publicado: (2023)

Significant roles of anti-aging protein klotho and fibroblast growth factor23 in cardiovascular disease
por: Ding, Hong-Ying, et al.
Publicado: (2015)

Fibroblast growth factor 23 and kidney function in patients with type 1 diabetes
por: Takashi, Yuichi, et al.
Publicado: (2022)

Fibroblast Growth Factor 23 (FGF23) and Disorders of Phosphate Metabolism
por: Saito, Tasuku, et al.
Publicado: (2009)

PKC regulates the production of fibroblast growth factor 23 (FGF23)
por: Bär, Ludmilla, et al.
Publicado: (2019)

The Measurement and Interpretation of Fibroblast Growth Factor 23 (FGF23) Concentrations
por: Heijboer, Annemieke C., et al.
Publicado: (2022)

Extra-cardiac findings in cardiovascular magnetic resonance: what the imaging cardiologist needs to know
por: Rodrigues, Jonathan C. L., et al.
Publicado: (2016)

Fibroblast growth factor 23 and bone mineralisation
por: Guo, Yu-Chen, et al.
Publicado: (2015)

Physiological Actions of Fibroblast Growth Factor-23
por: Erben, Reinhold G.
Publicado: (2018)

Upstream Regulators of Fibroblast Growth Factor 23
por: Ratsma, Danielle M. A., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_2qgdao4h0eem3s9af48vmu1fov